Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing. uri icon

authors

  • Vaidya, Hiteshi
  • Manish Kumar, MD

publication date

  • August 28, 2026